NICE: New Proportionate Approach To HTAs ‘Flexible, But Not Bespoke’

 
• By Eliza Slawther

NICE, the health technology assessment body for England and Wales, says its new proportionate approach to appraisals should be dynamic enough to “cope with the unique perspectives of new drugs” without being tailored to individual products or companies.

Jenniffer Prescott speaking at the NICE annual conference 2023

More from Market Access

More from Pink Sheet